Contraception
Volume 81, Issue 6 , Pages 520-524 , June 2010

Improving hysterosalpingogram confirmatory test follow-up after Essure hysteroscopic sterilization

  • Maryam Guiahi

      Affiliations

    • Division of Family Planning, Department of Obstetrics and Gynecology, Columbia University, New York, NY 10032, USA
    • Corresponding Author InformationCorresponding author. Presbyterian Hospital PH-69, New York NY 10032, USA. Fax: +1 212 305 6438.
  • ,
  • Kara N. Goldman

      Affiliations

    • Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL 60611, USA
  • ,
  • Margaret M. McElhinney

      Affiliations

    • Loyola University Chicago, Stritch School of Medicine, Maywood, IL 60153, USA
  • ,
  • Christopher G. Olson

      Affiliations

    • Loyola University Medical Center, Department of Obstetrics and Gynecology, Maywood, IL 60611, USA
    • Women's Center for Health, Edward Hospital, Naperville, IL 60540, USA

Received 20 August 2009 ,Revised 19 January 2010 ,Accepted 25 January 2010.

References 

  1. Kerin JF, Cooper JM, Price T, et al. Non-incisional hysteroscopic sterilization: results of a multicenter phase II study. J Hum Reprod. 2003;18:1223–1230
  2. Cooper JM, Carignan CS, Cher D, Kerin JF Selective Tubal Occlusion Procedure 2000 Investigators Group. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol. 2003;102:59–67
  3. Levie MG, Chudnoff SG. Office hysteroscopic sterilization compared with laparoscopic sterilization: a critical cost analysis. J Mini Inv Gynecol. 2005;12:318–322
  4. Connor VF. Essure: a review six years later. J Mini Inv Gynecol. 2009;16(3):282–289
  5. Kraemer DF, Yen P, Nichols M. An economic comparison of female sterilization of hysteroscopic tubal occlusion with laparoscopic bilateral tubal ligation. Contraception. 2009;80:
  6. Essure® 305 Instructions for Use. 9.09.09
  7. Levy B, Levie MD, Childres ME. A summary of reported pregnancies after hysteroscopic sterilization. J Mini Inv Gynecol. 2007;14:271–274
  8. Shavell VI, Abdallah ME, Diamond MP, Kmak D, Berman J. Post-Essure hysterosalpingography compliance in a clinic population. J Mini Inv Gynecol. 2008;15:431–434
  9. Elser DM, Yune JJ. Evaluation of Essure hysteroscopic sterilization outcomes in a community hospital. J Mini Inv Gynecol. 2007;14(Suppl 1):S41
  10. Savage UK, Masters SJ, Smid MC, Hung Y, Jacobson GF. Hysteroscopic sterilization in a large group practice. Obstet Gynecol. 2009;114:1227–1231
  11. Wittmer MH, Abimbola FO, Creedon DJ, Hartman RP. Hysterosalpingography for assessing efficacy of Essure microinsert permanent birth control device. AJR Am J Roentgenol. 2006;187:955–958
  12. Valle RF, Carignan CS, Wright TC. Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a pre-hysterectomy study. Fertil Steril. 2001;76:974–980
  13. Palmer SN, Greenberg JA. Transcervical sterilization: a comparison of Essure® permanent birth control system and Adiana® permanent contraception system. Rev Obstet Gynecol. 2009;2:84–92

 An abstract regarding data on the preintervention group was presented at the 37th Global Congress of the AAGL, October 28–November 1, 2008. The above abstract has been accepted for a poster presentation at the 58th annual American College of Obstetricians and Gynecologists annual clinical meeting in San Francisco May 15–19, 2010.

PII: S0010-7824(10)00039-9

doi: 10.1016/j.contraception.2010.01.019

Contraception
Volume 81, Issue 6 , Pages 520-524 , June 2010